Conference abstractPublished 8 Oct 2015
Intestinal endocrine cells as biomarkers for the diagnosis of irritable bowel syndrome
Professor of Gastroenterology and Hepatology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The diagnosis of Irritable Bowel Syndrome (IBS) in clinical practice is a diagnosis of exclusion, whereby diagnostic tests\r\nand invasive investigations are conducted to exclude other gastrointestinal diseases. Attempts have been made to achieve\r\na positive diagnosis based on symptoms assessment such as the Rome III criteria. However, symptom-based diagnosis is not\r\nwidely used in everyday clinical practice. Searches for biomarkers for the diagnosis of IBS that reflect pathological states have\r\nnot yielded any useful candidates. The duodenum contains the largest number of endocrine cells in the gastrointestinal tract,\r\nfollowed by the rectum. The densities of four of the five duodenal endocrine cell types have been found to be reduced in patients\r\nwith sporadic (non-specific) IBS. Chromogranin A (CgA) is a common marker for gastrointestinal endocrine cells. It has been\r\nthought that the cell density of CgA the duodenal endocrine cells, can be used as a biomarker for the diagnosis of IBS. Receiver\r\nOperator Characteristic (ROC) revealed areas under the ROC curve (ROCAUC) values of 0.97, and positive likelihood (+LH)\r\nand negative LR (-LH) of 18.5 and 0.14, respectively. This biomarker is simple, inexpensive, and easy to perform, and does not\r\nrequire sophisticated equipment or considerable experience. The density of PYY cells is reduced in the rectum of sporadic IBS\r\npatients, whereas that of somatostatin is increased. As biomarkers for the diagnosis of IBS, rectal PYY has a ROCAUC values\r\nof 0.96 and +LH and –LH 7.56 and 0.18, respectively. The corresponding values for somatostatin are 0.93, 7.20, and 0.23. These\r\nbiomarkers erform well in differentiating IBS from health and are better than Rome III criteria, which has +LH and –LH of\r\n3.53 and 0.39, respectively. Moreover, these biomarkers reflect an anatomical lesions occurring in the gastrointestinal tract of\r\nIBS patients, namely gastrointestinal endocrine cells.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectGastroenterology & Hepatology
- SubjectDiabetes & Endocrinology
- SubjectPathology & Lab Medicine
- BylineArticles whose byline prints “Magdy El-Salhy”
